METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster shows promise in tough pancreatic cancer trial
Disease control CompletedThis study tested an experimental immune-boosting drug called indoximod alongside standard chemotherapy for people with metastatic pancreatic cancer. The goal was to find the safest dose and see if the combination could help patients live longer. 157 adults with advanced pancreat…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
New combo targets pancreatic Cancer's DNA repair
Disease control CompletedThis study tested a new combination of drugs (ABT-888 plus chemotherapy) in 64 people with pancreatic cancer that had spread. The goal was to see if adding ABT-888, which blocks cancer cells from repairing damage, could shrink tumors better than chemo alone. Participants had to h…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo targets tough pancreatic cancer in early trial
Disease control CompletedThis early-phase trial tested a new oral drug called IOA-289, alone and with standard chemotherapy, in 16 adults with metastatic pancreatic cancer that cannot be removed by surgery. The main goal was to check safety and find the right dose. Researchers also looked at how the drug…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Real-World chemo patterns in pancreatic cancer revealed
Knowledge-focused CompletedThis study observed 799 adults with advanced or metastatic pancreatic cancer in Korea to see which chemotherapy treatments doctors actually use and why. Researchers tracked treatment choices, survival times, and quality of life. The goal was to understand real-world practice, not…
Matched conditions: METASTATIC PANCREATIC CANCER
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 00:52 UTC